Sunshine Biopharma Inc SBFM
π Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2008-08-15 |
| Shares Out. | 2,390,000 |
| Website | sunshinebiopharma.com/ β |
| Phone | 19543300684 |
| Employees | 50 |
| Revenue | $8.1M |
| Gross Profit | $2.2M |
| Net Income | -$1.2M |
| Free Cash Flow | -$5.9M |
| Total Assets | $27.9M |
| Total Liabilities | $6.4M |
| Equity | $21.5M |
About Sunshine Biopharma Inc
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
Sunshine Biopharma Inc is a publicly traded company under the ticker symbol SBFM on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
7 analysts (2026-07-01)

